322 related articles for article (PubMed ID: 35389264)
1. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
Chen J; Li Z; Guo J; Xu S; Zhou J; Chen Q; Tong X; Wang D; Peng G; Fang L; Xiao S
J Virol; 2022 Apr; 96(8):e0003722. PubMed ID: 35389264
[TBL] [Abstract][Full Text] [Related]
2. Porcine Epidemic Diarrhea Virus 3C-Like Protease Regulates Its Interferon Antagonism by Cleaving NEMO.
Wang D; Fang L; Shi Y; Zhang H; Gao L; Peng G; Chen H; Li K; Xiao S
J Virol; 2016 Feb; 90(4):2090-101. PubMed ID: 26656704
[TBL] [Abstract][Full Text] [Related]
3. Feline Infectious Peritonitis Virus Nsp5 Inhibits Type I Interferon Production by Cleaving NEMO at Multiple Sites.
Chen S; Tian J; Li Z; Kang H; Zhang J; Huang J; Yin H; Hu X; Qu L
Viruses; 2019 Dec; 12(1):. PubMed ID: 31905881
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
[TBL] [Abstract][Full Text] [Related]
5. Arterivirus nsp4 Antagonizes Interferon Beta Production by Proteolytically Cleaving NEMO at Multiple Sites.
Chen J; Wang D; Sun Z; Gao L; Zhu X; Guo J; Xu S; Fang L; Li K; Xiao S
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944180
[TBL] [Abstract][Full Text] [Related]
6. Porcine Deltacoronavirus nsp5 Cleaves DCP1A To Decrease Its Antiviral Activity.
Zhu X; Chen J; Tian L; Zhou Y; Xu S; Long S; Wang D; Fang L; Xiao S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32461317
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
Fung SY; Siu KL; Lin H; Yeung ML; Jin DY
Int J Biol Sci; 2021; 17(6):1547-1554. PubMed ID: 33907518
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease.
Zhang K; Eldin P; Ciesla JH; Briant L; Lentini JM; Ramos J; Cobb J; Munger J; Fu D
Elife; 2024 May; 12():. PubMed ID: 38814682
[TBL] [Abstract][Full Text] [Related]
10. Porcine deltacoronavirus nsp5 inhibits interferon-β production through the cleavage of NEMO.
Zhu X; Fang L; Wang D; Yang Y; Chen J; Ye X; Foda MF; Xiao S
Virology; 2017 Feb; 502():33-38. PubMed ID: 27984784
[TBL] [Abstract][Full Text] [Related]
11. Porcine Deltacoronavirus nsp5 Antagonizes Type I Interferon Signaling by Cleaving STAT2.
Zhu X; Wang D; Zhou J; Pan T; Chen J; Yang Y; Lv M; Ye X; Peng G; Fang L; Xiao S
J Virol; 2017 May; 91(10):. PubMed ID: 28250121
[TBL] [Abstract][Full Text] [Related]
12. Swine acute diarrhoea syndrome coronavirus (SADS-CoV) Nsp5 antagonizes type I interferon signaling by cleaving DCP1A.
Huang HX; Zhao CC; Lei XX; Zhang XY; Li YY; Lan T; Zhao BP; Lu JY; Sun WC; Lu HJ; Jin NY
Front Immunol; 2023; 14():1196031. PubMed ID: 37283741
[TBL] [Abstract][Full Text] [Related]
13. Spatial and temporal roles of SARS-CoV PL
Yan S; Wu G
FASEB J; 2021 Jan; 35(1):e21197. PubMed ID: 33368679
[TBL] [Abstract][Full Text] [Related]
14. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway.
Naik NG; Lee SC; Veronese BHS; Ma Z; Toth Z
Microbiol Spectr; 2022 Oct; 10(5):e0232222. PubMed ID: 36173315
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.
Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q
mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567
[TBL] [Abstract][Full Text] [Related]
16. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
Koudelka T; Boger J; Henkel A; Schönherr R; Krantz S; Fuchs S; Rodríguez E; Redecke L; Tholey A
Proteomics; 2021 Jan; 21(2):e2000246. PubMed ID: 33111431
[TBL] [Abstract][Full Text] [Related]
17. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.
Scott BM; Lacasse V; Blom DG; Tonner PD; Blom NS
BMC Genom Data; 2022 Apr; 23(1):25. PubMed ID: 35379171
[TBL] [Abstract][Full Text] [Related]
18. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.
Milligan JC; Zeisner TU; Papageorgiou G; Joshi D; Soudy C; Ulferts R; Wu M; Lim CT; Tan KW; Weissmann F; Canal B; Fujisawa R; Deegan T; Nagaraj H; Bineva-Todd G; Basier C; Curran JF; Howell M; Beale R; Labib K; O'Reilly N; Diffley JFX
Biochem J; 2021 Jul; 478(13):2499-2515. PubMed ID: 34198327
[TBL] [Abstract][Full Text] [Related]
19. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
Kouwaki T; Nishimura T; Wang G; Oshiumi H
Front Immunol; 2021; 12():700926. PubMed ID: 34249006
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
